While they might require a bit more research, they are far more likely to provide reliable, long-term benefits and a better overall experience
*Price shown applies to compounded GLP-1 2-Month plan paid upfront or with buy now, pay later programs
The peptide N-terminus is highly conserved between GLP-1, exendin-4 and oxyntomodulin, and as such, a large number of receptor contacts are also conserved, whereas these are more divergent when compared with exendin-P5 (Supplementary Table 1)
Depending on the patients response and glycemic control, the dose may be further increased
Blumenthal R, Morris P, Gaudino M, et al
Pre-existing Conditions: Individuals with a history of gallbladder disease, pancreatitis, or kidney issues should use these medications with caution